Evidence map›Paper›PMID 40035366›Full record

Observational studyActa obstetricia et gynecologica Scandinavica2025

Risk factors for lymph ascites after surgery for endometrial cancer and impact on lymphedema of the legs. A prospective longitudinal Swedish multicenter study.

Madelene Wedin, Karin Glimskär Stålberg, Ulrika Ottander, Åsa Åkesson, Gabriel Lindahl, Ninnie Borendal Wodlin, Preben Kjølhede

Abstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Acta obstetricia et gynecologica Scandinavica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Observational
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Madelene WedinDepartment of Obstetrics and Gynecology in Linköping, and Department of Biomedical and Clinical Science, Linköping University, Linköping, Sweden.ORCID 0000-0001-9940-4838
Karin Glimskär StålbergDepartment of Women's and Children's Health, Uppsala University, Uppsala, Sweden.ORCID 0000-0001-5527-8796
Ulrika OttanderDepartment of Clinical Sciences, Obstetrics and Gynecology, Umeå University, Umeå, Sweden.ORCID 0000-0002-1383-7753
Åsa ÅkessonDepartment of Obstetrics and Gynecology, Sahlgrenska University Hospital, and Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.ORCID 0000-0002-4938-2869
Gabriel LindahlDepartment of Oncology and Department of Biomedical and Clinical Science, Linköping University, Linköping, Sweden.ORCID 0000-0001-9494-1765
Ninnie Borendal WodlinDepartment of Obstetrics and Gynecology in Linköping, and Department of Biomedical and Clinical Science, Linköping University, Linköping, Sweden.ORCID 0000-0002-3730-7722
Preben KjølhedeDepartment of Obstetrics and Gynecology in Linköping, and Department of Biomedical and Clinical Science, Linköping University, Linköping, Sweden.ORCID 0000-0001-5702-4116

Funding

Cancerfonden CAN2013/620Forskningsrådet i Sydöstra Sverige FORSS-308611Forskningsrådet i Sydöstra Sverige FORSS-391311Forskningsrådet i Sydöstra Sverige FORSS-662141Forskningsrådet i Sydöstra Sverige FORSS-858611Forskningsrådet i Sydöstra Sverige FORSS-97790Regionala Forskningsrådet Uppsala/Örebro LUL-349271
6 · The paper itself

Abstract

introductionThe primary aim was to determine the occurrence of lymph ascites 4-6 weeks after surgery for endometrial cancer. Secondary aims were to assess risk factors for lymph ascites and the association with lymphedema of the legs. MATERIAL AND

methodsThis was a post hoc analysis of an observational prospective multicenter study, performed in 14 Swedish hospitals that included 235 women undergoing surgery for early-stage endometrial cancer between June 2014 and January 2018; 116 underwent surgery including pelvic and para-aortic lymphadenectomy and 119 had surgery without lymphadenectomy. Lymph ascites (free intraabdominal fluid or encapsulated pelvic or para-aortic fluid) was assessed by vaginal ultrasound 4-6 weeks postoperatively. Lymphedema was assessed using circumferential measurements of the legs preoperatively and 1 year postoperatively, enabling estimation of leg volume. A BMI-standardized leg volume increase ≥10% was classified as lymphedema. Evaluation of risk factors was performed using multiple logistic regression.

resultsLymph ascites 4-6-weeks postoperatively occurred in 28.5% (67/235) of the women. The estimated volume of the lymph ascites in these women was mean 28 mL (standard deviation 48 mL) and median 14 mL (interquartile range 2-36 mL). Lymphadenectomy was a risk factor for lymph ascites (aOR 9.97; 95% CI 4.53-21.97) whereas the use of minimally invasive surgery (aOR 0.50; 95% CI 0.25-0.99) reduced the risk. Twenty-two of 231 women (9.5%) developed lymphedema of the legs 1 year after surgery. The presence of lymph ascites was predictive of lymphedema (aOR 3.90; 95% CI 1.52-9.96).

conclusionsLymph ascites was common 4-6 weeks after surgery but in a low and clinically insignificant volume. Lymphadenectomy was a strong risk factor for lymph ascites and the use of minimally invasive surgery seemed to reduce the risk. Detection of lymph ascites at early postoperative follow-up may be a means of selecting patients at high risk of developing lymphedema after treatment with endometrial cancer for preventive measures against lymphedema progression.

Indexed as

AscitesEndometrial NeoplasmsLymphedemaLymph Node ExcisionPostoperative ComplicationsAgedFemaleHumansLegLongitudinal StudiesMiddle AgedProspective StudiesRisk FactorsSwedenendometrial cancerincidencelymph asciteslymphedemarisk factorssurgery

Identifiers

PMID40035366
PMCPMC11981105

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.